The Adverse Effects Profile of Teprotumumab.
J Clin Endocrinol Metab
; 108(9): e654-e662, 2023 08 18.
Article
in En
| MEDLINE
| ID: mdl-37071658
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug-Related Side Effects and Adverse Reactions
/
Graves Ophthalmopathy
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
J Clin Endocrinol Metab
Year:
2023
Type:
Article
Affiliation country:
United States